Baird analyst Joel Beatty revised the rating on Leap Therapeutics (NASDAQ:LPTX) stock, moving from Outperform to Neutral. This adjustment comes alongside a significant reduction in the price target, ...

AN2 Therapeutics , Inc. (NASDAQ:ANTX), currently trading at $1.23 and showing a significant 93.54% decline over the past year ...

XRP has entered a correction phase after failing to break above $3.20, testing support at $2.940 before showing signs of ...

There are two ways to play Puck in Dota 2: as a physical damage-dealer, or a caster that relies on his spells. While both ...

Walla Walla was awarded $108.5 million to complete the final phase of the U.S. 12 shift and expansion. This investment, the ...

The highly anticipated release of iOS 18.3 is set to take place on Monday, January 27, 2025, at 10:00 a.m. Pacific Time. This ...

Real Madrid and Arsenal barely broke a sweat, putting themselves in strong positions to qualify for the knockout stages.

The bedrock assumptions about how politics “works” and the rules for what a politician can or can’t do, no longer seem ...

Discover how intentional actions and tailored strategies can help you navigate midlife with energy, balance, and a renewed ...

The plan would reduce the state’s $7 billion general fund by $1.1 billion over 10 years. Losses would be partially offset by ...

Without a clear, internationally backed strategy for Gaza’s future, the ceasefire may simply be a temporary pause before the ...

Bitwise CIO Matt Hougan says that digital assets will likely go through a bullish phase in the next six months as the market ...